Pre- and non-occupational post-exposure prophylaxis for the prevention of HIV infection are recommended for adults at substantial risk of HIV. Women experiencing homelessness have increased risk of HIV infection compared with stably-housed women. We conducted a survey of 74 sheltered women at Lotus House Women's Shelter (Lotus House) in Miami to assess risk behaviour as well as knowledge and perception of pre- and non-occupational post-exposure prophylaxis in this population. Of surveyed women, 58.1% engaged in vaginal and/or anal sex while sheltered, and of sexually-active women 55.4% reported inconsistent condom use. 83.8% of women reported no concern regarding HIV acquisition due to their behaviour. Few women surveyed (20.8%) had previously heard of pre- or non-occupational post-exposure prophylaxis. The majority (58.3%) of respondents indicated receptiveness to these prevention methods when introduced. Those indicating that they would consider pre- or non-occupational post-exposure prophylaxis were significantly younger than those indicating that they would not consider these prevention strategies (p = 0.004). Education and referral for pre- and non-occupational post-exposure prophylaxis should be considered for sheltered women at risk of HIV infection. Additional research to optimise implementation of biomedical prevention strategies in this population is needed.
ShultzJMGreerPJLalotaM. HIV seroprevalence and risk behaviors among clients attending a clinic for the homeless in Miami/Dade Country, Florida, 1990–1996. Popul Res Pol Rev1999; 18: 357–372.
4.
GermanDLatkinCA. Social stability and HIV risk behavior: evaluating the role of accumulated vulnerability. AIDS Behav2012; 16: 168–178.
5.
CederbaumJAWenzelSLGilbertML. The HIV risk reduction needs of homeless women in Los Angeles. Women's Health Issues2013; 23: e167–172.
6.
WenzelSLTuckerJSElliottMN. Prevalence and co-occurrence of violence, substance use and disorder, and HIV risk behavior: a comparison of sheltered and low-income housed women in Los Angeles County. Prev Med2004; 39: 617–624.
7.
Centers for Disease Control and Prevention. Pre-exposure prophylaxis for the prevention of HIV in the United States – 2014 Clinical Practice Guideline 2014. Department of Health and Human Services, USA, 14 May 2014.
8.
BaetenJMDonnellDNdaseP. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med2012; 367: 399–410.
9.
ThigpenMCKebaabetswePMPaxtonLA. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med2012; 367: 423–434.
10.
Van DammeLCorneliAAhmedK. Preexposure prophylaxis for HIV infection among African women. N Engl J Med2012; 367: 411–422.
11.
MarrazzoJMRamjeeGRichardsonBA. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med2015; 372: 509–518.
12.
FlashCLandovitzRGilerRM. Two years of Truvada for pre-exposure prophylaxis utilization in the US. J Int AIDS Soc2014; 17: 19730.
13.
ReifSPenceBWHallI. HIV diagnoses, prevalence and outcomes in nine southern states. J Commun Health2015; 40: 642–651.
14.
AuerbachJDKinskySBrownG. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDs2015; 29: 102–110.
15.
SmithDKGrohskopfLABlackRJ. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep2005; 54: 1–20.
16.
MehtaSASilveraRBernsteinK. Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect2011; 87: 344–348.
17.
RodriguezAECastelADParishCL. HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas. J Acquir Immune Defic Syndr2013; 64: S68–S79.
18.
Centers for Disease Control and Prevention. Evaluation toolkit: patient and provider perspectives about routine HIV screening in health care settings.
19.
GrahamCACrosbyRASandersSA. Assessment of condom use in men and women. Annu Rev Sex Res2005; 16: 20–52.
20.
HalperinDT. Heterosexual anal intercourse: prevalence, cultural factors, and HIV infection and other health risks, Part I. AIDS Patient Care STDs1999; 13: 717–730.
21.
CunninghamIDiaz-EsteveCGonzalez-SantiagoM. University students and AIDS: some findings from three surveys – 1989, 1990, 1992. Buletin de Estudios Puertoriquenos1994; 6: 44–59.
HabartaNWangGMulatuMS. HIV testing by transgender status at Centers for Disease Control and Prevention-Funded Sites in the United States, Puerto Rico, and US Virgin Islands, 2009–2011. Am J Public Health2015; 105: 1917–1925.
24.
SeveliusJMReznickOGHartSL. Informing interventions: the importance of contextual factors in the prediction of sexual risk behaviors among transgender women. AIDS Educ Prev2009; 21: 113–127.
25.
FletcherJBKislerKARebackCJ. Housing status and HIV risk behaviors among transgender women in Los Angeles. Arch Sexual Behav2014; 43: 1651–1661.
26.
BowersJRBransonCMFletcherJ. Differences in substance use and sexual partnering between men who have sex with men, men who have sex with men and women and transgender women. Culture Health Sexuality2011; 13: 629–642.
27.
WilsonECJinHLiuA. Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013. PLoS One2015; 10: e0128971.
28.
MatthewsLTMooreLMilfordC. “If I don't use a condom … I would be stressed in my heart that I've done something wrong”: routine prevention messages preclude safer conception counseling for HIV-infected men and women in South Africa. AIDS Behav2015; 19: 1666–1675.
29.
Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States 2014, https://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf (accessed 1 June 2015).
30.
MagnusMKuoIShelleyK. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. Aids2009; 23: 1277–1284.
31.
KhawcharoenpornTKendrickSSmithK. HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care STDs2012; 26: 222–233.
32.
GalloPColucciACamoniL. Social and behavioural characteristics of a sample of AIDS Help-Line users never tested for HIV in Italy. Eur J Public Health2011; 21: 627–631.
33.
MacKellarDAValleroyLASecuraGM. Perceptions of lifetime risk and actual risk for acquiring HIV among young men who have sex with men. AIDS Behav2007; 11: 263–270.
34.
WhitesideYOHarrisTScanlonC. Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina. AIDS Patient Care STDs2011; 25: 365–370.
35.
CorneliALMcKennaKHeadleyJ. A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa. J Int AIDS Soc2014; 17: 19152.
36.
PrataNMorrisLMaziveE. Relationship between HIV risk perception and condom use: evidence from a population-based survey in Mozambique. Int Fam Plan Perspect2006; 32: 192–200.
37.
CorneliAWangMAgotK. Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. J Acquir Immune Defic Syndr2014; 67: 555–563.
